Study of Nivolumab Versus Placebo in Participants With High-Risk Breast Cancer (Q74279640)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Nivolumab Versus Placebo in Participants With High-Risk Breast Cancer |
clinical trial |
Statements
CheckMate 7FL (English)
0 references
A Randomized, Multicenter, Double-blind, Placebo-controlled Phase 3 Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer (English)
0 references
25 October 2019
0 references
20 June 2032
0 references
1,200
0 references
18 year
0 references